National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
CCI-779

 A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. CCI-779 blocks a protein involved in cell division, and may kill cancer cells. It is a type of rapamycin analog and a type of serine/threonine kinase inhibitor. Also called temsirolimus and Torisel.

Previous Definitions:CC-4047, CC-49, CC-5013, CC-8490, CC49-streptavidin
Next Definitions:cCLB8, CD134, CD34 antigen, CD40-ligand, CDDO